drugset

drugset / Trial / NCT02297867

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis

NCT02297867 ↗

Phase 1 Completed 6 enrolled Gwo Xi Stem Cell Applied Technology Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis.

Timeline

Start: 2015-07-13
Primary completion: 2017-12-18
Completion: 2018-03-27

Publications

Background Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS, Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC, Chiou TW. Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function. Cell Transplant. 2012;21(12):2753-64. doi: 10.3727/096368912X652959. Epub 2012 Jul 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ADSCs	Cell therapy	1 ml	Other

Indications